Molly Knewtson Email

Director Program Management . Aktiv Pharma Group

Current Roles

Employees:
82
Revenue:
$16.5M
About
Aktiv Pharma Group brings peace of mind to people at risk and their communities by developing simple-to-use emergency treatment technologies. Initially developed for the military, the ARAI™ is a prefilled auto-injector that uses single-hand, single-step activation. Now, ARAI is being developed to help people with life-threatening conditions in emergency situations, such as hypoglycemia, anaphylaxis and opioid overdose. Aktiv's platform technology has been used in a variety of form factors—including pre-filled syringes, auto-injectors, oral and topical dispensers, and IV transfer systems—which serve a broad range of medical applications. The flexible platform can be configured to carry a single drug solution or individually store multiple drug constituents that are either injected separately or automatically mixed just prior to injection. To learn more about career or investment opportunities, please visit www.aktivax.com.
Aktiv Pharma Group Address
100 Technology Dr
Broomfield, CO
United States
Aktiv Pharma Group Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.